» Articles » PMID: 39605713

Controlling Human Stem Cell-derived Islet Composition Using Magnetic Sorting

Overview
Journal bioRxiv
Date 2024 Nov 28
PMID 39605713
Authors
Affiliations
Soon will be listed here.
Abstract

Stem cell-derived islets (SC-islets) consists of multiple hormone-producing cell types and offer a promising therapeutic avenue for treating type 1 diabetes (T1D). Currently, the composition of cell types generated within these SC-islets currently cannot be controlled via soluble factors during this differentiation process and consist of off-target cell types. In this study, we devised a magnetic-activated cell sorting (MACS) protocol to enrich SC-islets for CD49a, a marker associated with functional insulin-producing β cells. SC-islets were generated from human pluripotent stem cells (hPSCs) using an adherent differentiation protocol and then sorted and aggregated into islet-like clusters to produce CD49a-enriched, CD49a-depleted, and unsorted SC-islets. Single-cell RNA sequencing (scRNA-seq) and immunostaining revealed that CD49a-enriched SC-islets had higher proportions of β cells and improved transcriptional identity compared to other cell types. Functional assays demonstrated that CD49a-enriched SC-islets exhibited enhanced glucose-stimulated insulin secretion both and following transplantation into diabetic mice. These findings suggest that CD49a-based sorting significantly improves β cell identity and the overall function of SC-islets, improving their effectiveness for T1D cell replacement therapies.

References
1.
Hogrebe N, Maxwell K, Augsornworawat P, Millman J . Generation of insulin-producing pancreatic β cells from multiple human stem cell lines. Nat Protoc. 2021; 16(9):4109-4143. PMC: 8529911. DOI: 10.1038/s41596-021-00560-y. View

2.
Hogrebe N, Ishahak M, Millman J . Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes. Cell Stem Cell. 2023; 30(5):530-548. PMC: 10167558. DOI: 10.1016/j.stem.2023.04.002. View

3.
Weng C, Xi J, Li H, Cui J, Gu A, Lai S . Single-cell lineage analysis reveals extensive multimodal transcriptional control during directed beta-cell differentiation. Nat Metab. 2020; 2(12):1443-1458. PMC: 7744443. DOI: 10.1038/s42255-020-00314-2. View

4.
Augsornworawat P, Hogrebe N, Ishahak M, Schmidt M, Marquez E, Maestas M . Single-nucleus multi-omics of human stem cell-derived islets identifies deficiencies in lineage specification. Nat Cell Biol. 2023; 25(6):904-916. PMC: 10264244. DOI: 10.1038/s41556-023-01150-8. View

5.
Maestas M, Bui M, Millman J . Recent progress in modeling and treating diabetes using stem cell-derived islets. Stem Cells Transl Med. 2024; 13(10):949-958. PMC: 11465181. DOI: 10.1093/stcltm/szae059. View